C

Corcept Therapeutics Tech Stack

Cortisol modulator biotech advancing oncology and endocrine treatments

Biotechnology Research Redwood City, California 501–1,000 employees Founded 1998 Public Company

Corcept is a public biotech company focused on cortisol-regulating molecules, with 30+ active clinical studies spanning oncology, endocrinology, metabolism, and neurology. The hiring mix—skewed toward senior roles (33 of 71 open positions) and anchored in healthcare, research, and sales—reflects a late-stage development org scaling commercial readiness alongside Phase I–III trial execution. Active projects center on oncology product launch preparation and GXP/regulatory compliance enhancements, signaling transition from discovery toward market deployment.

Tech Stack 18 technologies

Core StackSAS Salesforce NetSuite Python Veeva Concur Veeva Vault Word Outlook PowerPoint Excel Salesforce Marketing Cloud Microsoft Office Veeva QMS R SharePoint Box AuditBoard

What Corcept Therapeutics Is Building

◆Challenges

Access barriers
Remediating compliance gaps
Vendor management
Optimizing reimbursement strategies
Audit lifecycle management
Risk assessment
Standardizing document development process
Prioritizing critical software projects
Optimizing payer engagement
Implementing risk-based controls

▲Active Projects

Company-wide intern group presentation
New implementations
Clinical studies from phase i to phase iii for oncology drug candidates
Relacorilant clinical development
Launch of first oncology product in new orleans
2026 intern team group project
Develop templates, style guidelines, and sops for regulatory documentation
Gxp system enhancements
Inspection remediation activities
Clinical development plan for oncology molecules

Hiring Activity

Steady70 roles · 25 in 30d

Department

Sales

18

Healthcare

12

Research

11

Ops

6

Marketing

5

Data

3

Finance

3

Product

3

Seniority

Senior

33

Director

13

Intern

10

Manager

9

Mid

5

Junior

1

Notable leadership hires: Medical Director, Field Reimbursement Lead, Tax Director

Company intelligence

Find more companies like Corcept Therapeutics by tech stack, pain points and active projects

Get started free

About Corcept Therapeutics

Corcept Therapeutics develops cortisol modulators—molecules that regulate glucocorticoid receptor activity—for serious diseases including Cushing's syndrome, oncology, and metabolic conditions. Founded in 1998 and publicly traded, the company has discovered over 1,000 proprietary cortisol modulators and holds an FDA-approved treatment for hypercortisolism launched in 2012. Today the company operates a multi-program clinical pipeline with 30+ ongoing trials and is preparing oncology product launches. The team spans research, clinical development, regulatory affairs, reimbursement strategy, and commercial sales, supported by enterprise systems including Veeva (vault and QMS), Salesforce, NetSuite, and SAS for analytics.

HeadquartersRedwood City, California

Company Size501–1,000 employees

Founded1998

Hiring MarketsUnited States, Germany

Frequently Asked Questions

What is Corcept Therapeutics working on?

Corcept is advancing cortisol-modulating therapies through 30+ clinical studies across oncology, endocrinology, metabolism, and neurology. Current priorities include Phase I–III oncology trials, the relacorilant clinical development program, and preparation for an oncology product launch.

What tech stack does Corcept use?

Corcept operates on Veeva (Vault and QMS for regulatory/quality), Salesforce, NetSuite, SAS, Microsoft Office, Box, SharePoint, and AuditBoard. This stack supports clinical operations, reimbursement strategy, and regulatory compliance across the organization.